Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Pietropaolo

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Journal of Autoimmunity|August 21, 2018
Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetesLi Zhang, Tomasz Sosinowski, Aaron R Cox, et al.
Pediatric Diabetes|January 5, 2006
Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodiesMassimo Pietropaolo, Shui Yu, Ingrid M Libman, et al.
Plos One|September 17, 2014
Islet autoimmunity identifies a unique pattern of impaired pancreatic beta-cell function, markedly reduced pancreatic beta cell mass and insulin resistance in clinically diagnosed type 2 diabetesAngela Subauste, Roberto Gianani, Annette M Chang, et al.
Endocrinology|April 13, 2010
Humoral autoimmunity against the extracellular domain of the neuroendocrine autoantigen IA-2 heightens the risk of type 1 diabetesMichael P Morran, Anna Casu, Vincent C Arena, et al.
Diabetes Research and Clinical Practice|August 28, 2004
Infant diet and type 1 diabetes in ChinaElsa S Strotmeyer, Ze Yang, Ronald E LaPorte, et al.
Diabetes Care|January 25, 2014
Self-reported autoimmune disease by sex in the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) studyElizabeth Buschur, Aruna V Sarma, Massimo Pietropaolo, et al.
Diabetes Care|September 14, 2022
Commercially Available Insulin Products Demonstrate Consistency With Product Labeling Throughout All Seasons in the U.STimothy J Garrett, Sina Feizbakhsh Bazargani, Taylor Harmon, et al.
Diabetes|April 29, 2011
How does type 1 diabetes develop?: the notion of homicide or β-cell suicide revisitedMark A Atkinson, Jeffrey A Bluestone, George S Eisenbarth, et al.
Immunologic Research|July 1, 2011
A multivalent vaccine for type 1 diabetes skews T cell subsets to Th2 phenotype in NOD miceMing S Lin, Hubert M Tse, Meghan M Delmastro, et al.
The Annals of Thoracic Surgery|September 30, 2021
Inhibition of Cyclin Dependent Kinase 4/6 Overcomes Primary Resistance to Programmed Cell Death 1 Blockade in Malignant MesotheliomaHee-Jin Jang, Cynthia Y Truong, Eric M Lo, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Journal of Autoimmunity|August 21, 2018
Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetesLi Zhang, Tomasz Sosinowski, Aaron R Cox, et al.
Pediatric Diabetes|January 5, 2006
Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodiesMassimo Pietropaolo, Shui Yu, Ingrid M Libman, et al.
Plos One|September 17, 2014
Islet autoimmunity identifies a unique pattern of impaired pancreatic beta-cell function, markedly reduced pancreatic beta cell mass and insulin resistance in clinically diagnosed type 2 diabetesAngela Subauste, Roberto Gianani, Annette M Chang, et al.
Endocrinology|April 13, 2010
Humoral autoimmunity against the extracellular domain of the neuroendocrine autoantigen IA-2 heightens the risk of type 1 diabetesMichael P Morran, Anna Casu, Vincent C Arena, et al.
Diabetes Research and Clinical Practice|August 28, 2004
Infant diet and type 1 diabetes in ChinaElsa S Strotmeyer, Ze Yang, Ronald E LaPorte, et al.
Diabetes Care|January 25, 2014
Self-reported autoimmune disease by sex in the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) studyElizabeth Buschur, Aruna V Sarma, Massimo Pietropaolo, et al.
Diabetes Care|September 14, 2022
Commercially Available Insulin Products Demonstrate Consistency With Product Labeling Throughout All Seasons in the U.STimothy J Garrett, Sina Feizbakhsh Bazargani, Taylor Harmon, et al.
Diabetes|April 29, 2011
How does type 1 diabetes develop?: the notion of homicide or β-cell suicide revisitedMark A Atkinson, Jeffrey A Bluestone, George S Eisenbarth, et al.
Immunologic Research|July 1, 2011
A multivalent vaccine for type 1 diabetes skews T cell subsets to Th2 phenotype in NOD miceMing S Lin, Hubert M Tse, Meghan M Delmastro, et al.
The Annals of Thoracic Surgery|September 30, 2021
Inhibition of Cyclin Dependent Kinase 4/6 Overcomes Primary Resistance to Programmed Cell Death 1 Blockade in Malignant MesotheliomaHee-Jin Jang, Cynthia Y Truong, Eric M Lo, et al.
Pageof 8